We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Generic Drugmakers Back Ruling Against Tribal Immunity For Patent Reviews

Mealey's (March 12, 2019, 8:48 AM EDT) -- WASHINGTON, D.C. — A case in which a drugmaker is trying to use an Indian tribe’s sovereign immunity to shield it from inter partes review (IPR) of its patents is a...
To view the full article, register now.